Revision of Prior Period Financial Statements - Schedule of Revised Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Assets
Accounts receivable, net	$ 23,867	$ 19,790
Total current assets	172,792	104,295
Total assets	306,212	117,523
Liabilities and Stockholders’ Equity
Accrued liabilities	32,586	26,688
Deferred revenue	1,251	1,223
Total current liabilities	52,066	30,334
Total liabilities	170,803	65,386
Accumulated other comprehensive income (loss)	82	(16)
Accumulated deficit	(260,393)	(205,825)
Total stockholders’ equity	135,409	52,137	$ 79,341	$ 93,041
Total liabilities and stockholders’ equity	$ 306,212	117,523
As Reported
Assets
Accounts receivable, net		21,977
Total current assets		106,482
Total assets		119,710
Liabilities and Stockholders’ Equity
Accrued liabilities		26,570
Deferred revenue		1,243
Total current liabilities		30,236
Total liabilities		65,288
Accumulated other comprehensive income (loss)		(41)
Accumulated deficit		(203,515)
Total stockholders’ equity		54,422	79,553
Total liabilities and stockholders’ equity		119,710
Adjustment
Assets
Accounts receivable, net		(2,187)
Total current assets		(2,187)
Total assets		(2,187)
Liabilities and Stockholders’ Equity
Accrued liabilities		118
Deferred revenue		(20)
Total current liabilities		98
Total liabilities		98
Accumulated other comprehensive income (loss)		25
Accumulated deficit		(2,310)
Total stockholders’ equity		(2,285)	$ (212)
Total liabilities and stockholders’ equity		$ (2,187)